Atopic dermatitis: dupilumab and crisaborole could herald a new era in treatment
Atopic dermatitis can have a devastating effect on quality of life, but there have been no major changes to the way it has been treated for over 15 years. Now, two new therapies — dupilumab, a biologic for severe disease, and crisaborole, a topical small molecule drug for milder disease &mdash…
Published: 23 February 2017
